NET263 Ltd. (002467.SZ) major shareholder Lee Xiaolong plans to reduce his shareholding by no more than 2%.
Announcement of 263 (002467.SZ): The company's controlling shareholder, Mr. Li Xiaolong, plans to reduce his holdings of the company's shares through block trading and centralized bidding from April 9, 2026 to July 8, 2026, not exceeding 27.5074 million shares (2% of the total share capital of the company).
Announcement from NET263 Ltd. (002467.SZ): The company's controlling shareholder, Mr. Li Xiaolong, plans to reduce his holdings of the company's shares through block trades and centralized bidding from April 9, 2026 to July 8, 2026, with a total of no more than 27.5074 million shares (2% of the total share capital of the company).
Related Articles
CHINA GLASS (03300) issued a profit warning, expecting an annual loss of no more than 5.8 billion yuan.
CITIC (00267): Citic Press Corporation (300788.SZ) achieved a net profit attributable to the parent company of 130 million yuan in 2025, representing a year-on-year growth of 9.63%.
CHINARES PHARMA (03320): CHINARES PHARMA plans to list and sell approximately 5.88% of its equity stake in Tianmai Biotechnology.
CHINA GLASS (03300) issued a profit warning, expecting an annual loss of no more than 5.8 billion yuan.
CITIC (00267): Citic Press Corporation (300788.SZ) achieved a net profit attributable to the parent company of 130 million yuan in 2025, representing a year-on-year growth of 9.63%.
CHINARES PHARMA (03320): CHINARES PHARMA plans to list and sell approximately 5.88% of its equity stake in Tianmai Biotechnology.
